Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

shanghai agrochina chemical co. ltd. - triasulfuron - water dispersible granule - triasulfuron urea-sulfonyl active 750.0 g/kg - herbicide

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

sabakem pty ltd - propiconazole; liquid hydrocarbon - emulsifiable concentrate - propiconazole triazole active 250.0 g/l; liquid hydrocarbon solvent other 600.0 g/l - fungicide

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

axichem pty ltd - propiconazole; liquid hydrocarbon - emulsifiable concentrate - propiconazole triazole active 550.0 g/l; liquid hydrocarbon solvent other 371.0 g/l - fungicide

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

4 farmers australia pty ltd - azoxystrobin; cyproconazole - suspension concentrate - azoxystrobin pyrimidine active 200.0 g/l; cyproconazole triazole active 80.0 g/l - fungicide

Australia - English - Department of Health (Therapeutic Goods Administration)

merck healthcare pty ltd - lutropin alfa, quantity: 75 iu - injection, powder for - excipient ingredients: methionine; sodium hydroxide; phosphoric acid; sucrose; polysorbate 20; dibasic sodium phosphate dihydrate; monobasic sodium phosphate monohydrate - luveris in association with a recombinant follicle stimulating hormone (fsh) preparation is recommended for the stimulation of follicular development in women with severe lh and fsh deficiency. in clinical trials, these patients were defined by an endogenous serum lh of less than 1.2 iu/l.

Australia - English - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - interferon beta-1b, quantity: 0.25 mg/ml - injection, powder for - excipient ingredients: albumin; mannitol - betaferon is indicated for the treatment of: - ambulatory patients with relapsing-remitting multiple sclerosis (ms) characterised by at least two attacks of neurologic dysfunction over a two year period followed by complete or incomplete recovery. - betaferon is also indicated for the reduction of frequency and severity of clinical relapses, and for the slowing of progression of disease in patients with secondary progressive multiple sclerosis. - the treatment of patients with a single clinical event suggestive of multiple sclerosis and at least two clinically silent magnetic resonance imaging (mri) lesions characteristic of multiple sclerosis, if alternative diagnoses have been excluded.

Australia - English - Department of Health (Therapeutic Goods Administration)

merck serono australia pty ltd - metacresol,somatropin,water for injections -

Australia - English - Department of Health (Therapeutic Goods Administration)

merck healthcare pty ltd - cetrorelix, quantity: 0.25 mg - injection, powder for - excipient ingredients: mannitol - indications: prevention of premature luteinization and ovulation in patients undergoing a controlled ovarian stimulation, followed by oocyte pick up and assisted reproductive techniques. in clinical trials cetrotide was used with human menopausal gonadotrophin (hmg), however limited experience with recombinant fsh suggested similar efficacy.

Australia - English - Department of Health (Therapeutic Goods Administration)

merck healthcare pty ltd - somatropin -

Australia - English - Department of Health (Therapeutic Goods Administration)

kls martin australia pty ltd - 45716 - suture knot pusher, reusable - a hand-held manual surgical instrument that enables the user performing an internal suturing procedure (e.g., suturing a heart valve in the thoracic cavity) to advance suture knots created extracorporeally to the point of appropriate suture tension. it is a long, thin, rod-like device that has a guiding mechanism (e.g., an eyelet or groove) at its distal end, allowing it to be steered down one end of the suture as it pushes the knot with its blunted nose. saline may be used to lubricate the suture and the knot pusher if necessary. this is a reusable device.